CYP2B6 and adrenal cortex carcinoma: Our study firstly indicated that the cumulative dose of mitotane and polymorphisms of CYP2B6 516 and CYP2B6 26570 might significantly affect mitotane plasma trough concentrations in Chinese ACC patients, which suggests the importance of further prospective clinical investigations.